Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways
Aging · 2024
DOI: 10.18632/aging.205829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Xiao-Xiao Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Hauptthemen laut MEDLINE: Angiotensin II, Atrial Fibrillation, Benzylisoquinolines, Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
- State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Cardiovascular Surgery, General Hospital of Northern Command, Shenyang 110016, Liaoning, China.
Zitieren
APA
Jiang, X. X., Zhang, R., & Wang, H. S. (2024). Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways. Aging. https://doi.org/10.18632/aging.205829
Vancouver
Jiang XX, Zhang R, Wang HS. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways. Aging. 2024. doi:10.18632/aging.205829
BibTeX
@article{Jiang2024,
author = {Jiang, Xiao-Xiao and Zhang, Ri and Wang, Hui-Shan},
title = {Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205829}
}
EUVIMED